Vicebio
ExitedVicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections.
Vicebio is tracked in the Tech.eu funding database. Based in London, UK; active in Healthtech. Acquired by Sanofi in 2025. Data as of Nov 2026.
London, UKwww.vicebio.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Jul 2025
Value
€1.4B
Acquiror
Sanofi (France)
Related news
Similar companies
same sector, similar size- Clinithink—UK · Healthtech
- Chiron Health AI—UK · Healthtech
- Ascentys—UK · Healthtech
- Stent Tek—UK · Healthtech
- MYndspan—UK · Healthtech
- Neoss—UK · Healthtech
Global coverage: FundingData